Literature DB >> 21204630

Role of Service Providers of Needle Syringe Program in Preventing HIV/AIDS.

Tzu-I Tsai1, Donald E Morisky, Yi-Ming A Chen.   

Abstract

To provide a national-scale picture of the needle exchange program in Taiwan, this study examined (a) needle and syringe program (NSP) service providers' AIDS-relevant harm reduction knowledge and attitudes; and (b) NSP services schemes and operation barriers encountered by different service modalities. A self-administrated questionnaire was mailed to all participating NSP service providers in Taiwan. A total of 414 service providers completed the postal survey. This study confirms that NSP service providers play an essential role in providing comprehensive activities to reduce HIV/AIDS infection for drug misusers. Knowledge and attitudes of service providers were found to be independently and important predictors of NSP service provisions. Community-based and clinical-based providers had diverse service schemes and encountered operation problems due to different organization characteristics, professional training, and ethical concern. For the future planning of NSP programs, service-specific education and professional support are essential component of service delivery and quality.

Entities:  

Mesh:

Year:  2010        PMID: 21204630     DOI: 10.1521/aeap.2010.22.6.546

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  4 in total

1.  Pharmacists and harm reduction: A review of current practices and attitudes.

Authors:  Tyler Watson; Christine Hughes
Journal:  Can Pharm J (Ott)       Date:  2012-05

2.  The case of a needle exchange policy debate in Fresno, California.

Authors:  Kris Clarke
Journal:  Crit Soc Policy       Date:  2015-10-05

3.  Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study.

Authors:  Andreas Kimergård; Jim McVeigh
Journal:  Harm Reduct J       Date:  2014-07-02

4.  Effects of education on harm-reduction programmes.

Authors:  Shu-Yu Lyu; Lien-Wen Su; Yi-Ming Arthur Chen
Journal:  Lancet       Date:  2011-08-16       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.